Niche vaccine player Valneva, UK tie up in coronavirus R&D and manufacturing deal esagonowsky Mon, 07/20/2020 – 11:16 More: Niche vaccine player Valneva, UK tie up in coronavirus R&D and manufacturing deal Source: fierce
read moreBayer plays the long game with plans to double workforce at Berkeley biologics site aliu Mon, 07/20/2020 – 10:18 More: Bayer plays the long game with plans to double workforce at Berkeley biologics site Source: fierce
read moreFiercePharmaPolitics—States still exploring drug pricing despite congressional gridlock esagonowsky Mon, 07/20/2020 – 09:57 More: FiercePharmaPolitics—States still exploring drug pricing despite congressional gridlock Source: fierce
read morePfizer, BioNTech ink U.K. supply pact for 30M COVID-19 vaccine doses kblankenship Mon, 07/20/2020 – 09:26 More: Pfizer, BioNTech ink U.K. supply pact for 30M COVID-19 vaccine doses Source: fierce
read moreInterim six-month data of RPGR gene therapy shows significant vision improvement in patients with X-linked retinitis pigmentosa More: Janssen/MeiraGTx sight loss gene therapy hits targets Source: News
read moreGSK to make equity investment of £130m in CureVac as part of the deal More: GSK and CureVac form mRNA tech collaboration Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals